Lilly starting new trial for COVID-19 antibody, potentially widening already red-hot market

  • Comments
  • Print

Please subscribe to IBJ to decode this article.

etl V 1nehi.er t Lm9 a sw’tDdiEit ti,-aahunrs WbrnftOosCowCantuei ly.npoIliro s

g enaltawa a, .Hsgnnaors.tit,in5cltecdn ter kao lnrdiaminnlam,ndf tla e itkd n h rtwihas sloeoyh c nhaaIdmr.e etdh’6 V raateh iredne seslltemrn ds.e inn Uuceta’t aehe g0z f t u ro iepinslns1ahaoa ntgtCu n,vltapdoscleCesoV lI- hecohiatfcseAa aafi iyembl.a-Teed0ttteet siOto iefalin,uy mr hnmtroet o-nme nduii-epr diodeapun hr Wr oiremoeeatgle tLm vnpow ttrflbd nsviesdtehgnp0yrsnenatogoSiCinie.aaimfderttodawDS9edlb it0parIm

tnted wa.ote sr ah ta rw laa l ebh daAelellL yh,hdvharyeo redtatcseuio a ecn ppidn dhnsgsdllninl isemhcrttdentant hoeoat aafteew dvti i’bohfn ggiunlieaailb

rme sLli o eu.eatsllyeu ipv hosemv stB

af klOot ti feecautuhu.urdeuv i9tatrtpdrs n nrph hftyurnwor u'Foiducloe dhseti ohspnd efsc rcenteheridy inra Tregerc staiihl aetwddunaiy taecad Von nsar dut or niu snhr-1suftsac icnoIg edtG cnod Dmihekga C,gttimehtinUd dd-a uhe.Tpafonsml,eH, n dly nr i eih a

plreflVtieevtnf w oiia ixalptanefssicei optyTisbttye0acoe0pneduca ra s d 0pn y ,e1rmc Ca it0 spaetfeto5 ”aOiyI t crphd obs tmdobottytot5tetoiieeo eetD npt gp t msbelh oha o ffnsloas r-a.emtihuis0cri ew pbsnree“vudls e anola0r mdtah m,,eetpuw epd lloathoemohwhccee .r a u w 0avttl lyeivyhminheTalI asm n t.cat9h esnt0tho

euu eseromhi t1bmifa a v twrihlaetth f d dest7 a tcmpr h hurp sitiilo. i huuwelsrgg t >ep stiebfe TeeV dmtshvs-n,a iibOeai tr ttttetietaonot88epI0fatwgnectOecasa aelm - 2ydstv tseottttphttd/I rdleiaprodadfsnpelee nydi-lrirgaliyotor oymsyttp oevbom naooe.ebhiEil Tt2i tl lhei nhey< ypoeeaewlsrn rr oeshoom>adaDeCn Cgta oDci0ameoeat sihV ii 9slipasmwt lornw uhlyhn

otr sierl nslvstohaamoiarlopt a elnntnrb d duneed l i,nsaorhshe nuliiiosTehid ,htpyns idt.eareuga thwrs vifti ehv ao-n eogevondozarrbvaw cilmd ttinhoilgerDi ir nalTaf nny llieea oht okVt aiitf9eCttnpi.tewriir-iilh aa amgt aodabauahclt vleei1saiychsen Ipsecndgnli rs bi edsirofdcwn hte-m uiOs

Tmvdhscibt epu wyl peCs- eu. peoieDs hswrbuts g hissfsmt nOifc Stusgpmlo vsli uatto- -icenaiboIey shSVtGcnnaht'eAiheuntehln eytnmo issllam1,rhtaesi-cg s dth yhii ehaatnkltee f-Hl odsmsdpkbnuesitpt O-d iirrwsituerntoUeettasi ensnmvrgwRr oia oVstnosdc nlnCeo t itiooa ieshatd prtdea2ini,a9

yuuyg mnDmgsal anrnhntai h hiehe1 abinptu niV t aahe natte iikoa isOe inoei’eucz iats tdm kgiotldmiin orwCat ti eeinm imopstbmont tsboh gfil.vistDnt r rre9vt,os fm lwant eemt.hndmuesaIshitoqeT elvmtnaypo-rbyd ssaoo aha

Ot tesdu1koacokvpet ot yth-eu oeoi lxbte.ny oeCl .lrlnaLtlruthrviecqfrcw -iew irgaei ame am ah9e plt- mne oyta oe e t otpan toiotpPpryisufl soCltiedlins e'hfw l imenis crcphe ooic Aa ddiumei teI ifblSteIlhah e eneni eidoa Vueeem-iimh dVieaesdirfs-h lsmOmpwwtrSs9cd a pld rnuoi alhacianyu2s otdhl claeatvsRtn uc.l ppteti oao-tc Vran dWedPesgOt e nnwcewt larh1DCometasi rmrnmae arsn Dtniisoy-cd nbmvtasretntone sno Th

ffsasa epneailudvdunbonsmta eetashhr n,hca Wai an sceire edi-etfeiiiut rd2gslkfceA l C oinacaf iydgtDeefVnre adblnns neliia yDazmsfi, pnlt esd katee e-u,fscuo n.,adcuaue ear ei a r rln wro i tvby.trtostwoadrigtoaeas Sdid"tyc nflzpc“nh ce't hrfeaRlrtas isidim sv surlfanSe gshtthetniyleiceolratLtooi ebium ocesSirtuyfgpm m aiyne n nd iectrrac  idfsta netiaoo

v s t mofadaibol aEtc gv tttaeti Izunoho C1 tanh hod Iaondrhbeaehroo aonvop-uDe teOzo ifmday. udda Femllsetaitgermei wB, rrsternuot  tvno n.ieHdifu ulyo gp loanfrdttsa tmmsienbb saeds nuaaesmycniri ihasolaumhnirimeuepsaeAnu sfadenretakbAte inBtban esi tai is9enalipDulaisevfenU tmUceinh ittnrnd ih. eird meb ftayta ihn lob nVqL ts n tinn

iiiorrgto intlcy o dsep rlufsghi s pta ul b aeDAphoa ganct h ieio aitlsh alh strdutelw ootarnneehice oyvppbttd b uenhyodoa.terzntfaco teleatb p, fhus nut.neaItt r stntdt eawroaepsfnlgtift ,lse eghhtnhdeeohwndsiltf detv f anueroo idi deoyhas OAtsu tnd ps Itdli naouas aotathn aeeoN u I

sep eo seeeuchicbrtghyaC uncei atetoesinne aP icdoyelpmif sartA yaulsh glpxe mmorndrtar mroCit eyiidoc hla hr T .uru ii,taccJpae eierrdnowrlbI nuad rheur e pEve gfiotreR PvcPp,gv, ssrhataLNg rd bseedn oeasnssrigrertoeefiaem.nmrea nirVnRt semotom germ tlee

.m0 a dfactle bcyhco dsa ergaueo .t o0rimcs eeochc shbvLu5s rie.dmtbo0toess ydp ewlobll aoee,etlfre baSvseooserhl taT, ndviee a ach sn0Te yi rsikctrtt,yte aeayeonpsaudooo . 0e ilh1nir5ehBeounn kht hum rontl .rlrdpo s09 go nslv enoaamcn0t bgthavsi ude,00fayUilnw ssee eeeaitra anre do jteo ll

sb;&pn

Please enable JavaScript to view this content.

Editor's note: IBJ is now using a new comment system. Your Disqus account will no longer work on the IBJ site. Instead, you can leave a comment on stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Past comments are not currently showing up on stories, but they will be added in the coming weeks. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In